pharmaceuticals

MRK Earnings: Merck & Co. Q1 adj. profit rises, beats estimates

April 24, 2025

JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 financial results

April 15, 2025

UNH Earnings Preview: Will UnitedHealth’s Q1 earnings beat expectations?

April 10, 2025

Deals and R&D in focus as Johnson & Johnson gears up for Q1 earnings

April 8, 2025

AngioDynamics (ANGO) Q3 2025 loss narrows; sales down 4%

April 2, 2025

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness

March 25, 2025

Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance

March 20, 2025

Illumina (ILMN) expects adjusted EPS of approximately $4.50 for FY25

March 11, 2025

Earnings Summary: Highlights of Baxter International’s Q4 2024 report

February 20, 2025

MDT Earnings: Medtronic reports higher Q3 2025 revenue and adj. profit

February 18, 2025

Earnings Summary: Moderna slips to loss in Q4; revenue down 66%

February 17, 2025

Earnings: CVS Health reports a sharp fall in Q4 profit; revenue up 4%

February 12, 2025

Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report

February 6, 2025

LLY Earnings: Eli Lilly Q4 2024 profit more than doubles; revenue up 45%

February 6, 2025

MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth

February 4, 2025

PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2024 financial results

February 4, 2025

AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth

January 31, 2025

Important takeaways from Abbott Laboratories’ Q4 2024 earnings report

January 22, 2025

Highlights of Abbott Laboratories (ABT) Q4 2024 results

January 22, 2025

JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2024 earnings results

January 22, 2025

Johnson & Johnson (JNJ) likely to report mixed results for Q4 2024

January 15, 2025